search index hum-molgen

 

HUM-MOLGEN events
HIGH-THROUGHPUT TECHNOLOGIES: Summit and Exposition
 
Cambridge Healthtech Institute , Philadelphia, Pennsylvania
June 19-21, 2000

The role of screening for drug discovery has changed significantly in recent years as a result of the move to much higher throughput technologies, including miniaturization, greater diversity of lead sources, and increasingly sophisticated assays, as well as more extensive genomic information for identification and validation of targets and the application of pharmacogenomics. In an ever-increasing effort to reduce the need for random screening, drug developers are looking to chemoinformatic-based strategies for mining and interpretation of screening data, structure or activity-based modeling, or the identification of leads, as well as for the greater understanding of drug target interaction. These topics will all be covered in CHI’s “Seventh Annual High-Throughput Technologies Summit and Exposition.” This three-day event offers multitrack sessions allowing you to create your own custom conference by selecting the sessions most suitable to your needs. Complementing the outstanding scientific agenda is a full range of exhibitors supplying screening leads, automation equipment, assays, genomics, and informatics, among other products and services needed for success in this field. Plan now to take advantage of such convenience in one place.

Organized by:

Cambridge Healthtech Institute

Deadline for Abstracts:

May 5, 2000

Registration:

Email for Requests and Registration: jlaakso@healthtech.com
 
 

Posted by: Jennifer Laakso   Host: 140.239.39.137
date: January 20, 2000 16:27:52
Generated by meetings and positions 2.0 by Kai Garlipp
Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany.
4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.